salmeterol xinafoate · Powder

What changed in the last 90 days

Every detected change for salmeterol xinafoate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in beta2-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• aclidinium bromide and formoterol fumarate· 1 maker
• albuterol sulfate and budesonide· 1 maker
• arformoterol tartrate inhalation solution· 1 maker
• beclomethasone dipropionate/formoterol fumarate/glycopyrrolate· 1 maker
• budesonide and formoterol fumarate· 1 maker
• budesonide, glycopyrrolate, and formoterol fumarate· 1 maker
• fluticasone furoate and vilanterol· 1 maker
• fluticasone furoate and vilanterol trifenatate· 1 maker
• fluticasone furoate, umeclidinium bromide and vilanterol trifenatate· 1 maker
• ipratropium bromide and albuterol· 1 maker
• levalbuterol inhalation solution· 1 maker
• mometasone furoate and formoterol fumarate dihydrate· 1 maker

Common questions

Is Salmeterol xinafoate in shortage right now?

No. FDA does not currently list Salmeterol xinafoate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Salmeterol xinafoate?

13 companies have marketed Salmeterol xinafoate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Salmeterol xinafoate cost?

The typical pharmacy pays about $6.74 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.